Search by Drug Name or NDC
NDC 39822-0190-01 Acetazolamide 500 mg/5mL Details
Acetazolamide 500 mg/5mL
Acetazolamide is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by XGen Pharmaceuticals DJB, Inc.. The primary component is ACETAZOLAMIDE SODIUM.
Product Information
| NDC | 39822-0190 |
|---|---|
| Product ID | 39822-0190_0e357e3c-5eda-d38c-e063-6294a90ac071 |
| Associated GPIs | 37100010102105 |
| GCN Sequence Number | 008163 |
| GCN Sequence Number Description | acetazolamide sodium VIAL 500 MG INJECTION |
| HIC3 | R1E |
| HIC3 Description | CARBONIC ANHYDRASE INHIBITORS |
| GCN | 34680 |
| HICL Sequence Number | 003640 |
| HICL Sequence Number Description | ACETAZOLAMIDE SODIUM |
| Brand/Generic | Generic |
| Proprietary Name | Acetazolamide |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Acetazolamide |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 500 |
| Active Ingredient Units | mg/5mL |
| Substance Name | ACETAZOLAMIDE SODIUM |
| Labeler Name | XGen Pharmaceuticals DJB, Inc. |
| Pharmaceutical Class | Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA040784 |
| Listing Certified Through | 2025-12-31 |
Package
NDC 39822-0190-01 (39822019001)
| NDC Package Code | 39822-0190-1 |
|---|---|
| Billing NDC | 39822019001 |
| Package | 1 VIAL, GLASS in 1 CARTON (39822-0190-1) / 5 mL in 1 VIAL, GLASS |
| Marketing Start Date | 2009-03-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |